William  Hornsby

Dr. William Hornsby


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Cardiopulmonary Physical Therapy Journal
Verified
Journal Article
Closed access
ENEric Nolen-Doerr
Eric Nolen-Doerr
KCKent Ma Crick
Kent Ma Crick
CSChandan Saha
Chandan Saha
MGMary de Groot
Mary de Groot
YPYegan Pillay
Yegan Pillay
WWilliam Hornsby
William Hornsby
Objective: The 6-minute walk test (6MWT) is a measure that is routinely used to assess a response to treatment for cardiopulmonary diseases such as pulmonary fibrosis and congestive heart failure. The measure has never been verified as a valid measure of exercise capacity in the highly prevalent patient population of type 2 diabetes (T2DM). This study investigated the correlation between the 6MWT and graded exercise testing (GXT) in an effort to validate the 6MWT as a quality tool for assessing exercise capacity in adults with T2DM. Research Design and Method: This is a secondary data analysis of Program ACTIVE II, a randomized controlled trial designed to assess the effectiveness of 2 behavioral interventions on depression and glycemic outcomes in adults with T2DM. The correlation of 6MWT and predicted VO2 max (PVO2M) using GXT was examined in a subsample of participants at the time of study enrollment and at postintervention. Results: PVO2M showed a significant correlation with 6MWT distance both at baseline (r = 0.57, P = .014) and postintervention (r = 0.66, P = .037). The regression analysis of baseline data revealed that 6MWT distance alone explained 45% (F = 13.03, P = .0024) of the variability in PVO2M. When combined with the SF-12 physical health component score (Physical Components Subscale [PCS]), 6MWT explained 66% (F = 13.62, P < .001) of the variance in PVO2M. After adjusting for PCS, 6MWT distance explained an additional 30% variability in PVO2M. Conclusions: Findings from this study indicate that the 6MWT and predicted exercise capacity are significantly correlated. The 6MWT can be used to estimate exercise capacity in adults with T2DM.

22 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
YPYegan Pillay
Yegan Pillay
WWilliam Hornsby
William Hornsby
CSChandan K. Saha
Chandan K. Saha
jay H shubrookjay H shubrook
jay H shubrook
KCKent A. Crick
Kent A. Crick
MGMary de Groot
Mary de Groot
Background/Objectives: This study is an investigation of the occurrence, remission and recurrence of major depressive disorders (MDDs) in adults with type 2 diabetes (T2DM). Methods: Interviews were conducted with individuals (N = 176) who met the criteria for MDD using the Structured Clinical Interview for the DSM-IV-TR (SCID). Results: N = 176 T2DM adults, with a mean (SD) age of 55.5 (10.4) years, 74% of whom were female and 62% were white, completed the Structured Clinical Interview for the DSM-IV-TR (SCID). A mean (SD) number of 1.8 (0.9) episodes of major depression (MDD) were recorded from birth to the date of interview, with a mean (SD) onset age of the first episode of 40.4 (15.9) years. Median (IQR) MDD episode duration was 13.9 (5.6–31.9) months and the median (IQR) cumulative lifetime exposure duration to MDD was 33 (12.9–63.1) months. Kaplan–Meier survival analysis along with the frailty model, to account for the correlation among multiple recurrences or remissions within a subject, indicated that the median first episode duration was shorter than the median second episode duration (14 vs. 37.9 months, p < 0.0001). Of those who had at least three episodes, the median second episode duration was shorter than the median third-episode duration (13.0 vs. 28.0 months, p = 0.006). The median recurrence time following first remission was significantly longer than the median recurrence time following second remission (138.0 vs. 80.6 months, p = 0.02). Conclusions: These results document that clinical depression is recurrent in adults with T2DM. Moreover, depressive episodes in individuals with T2DM are persistent well beyond episode durations observed in the general population.